高级检索
当前位置: 首页 > 详情页

Effect of Platelet-Rich Fibrin on Fat Grafting in Animal Models: A Meta-Analysis

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing, Peoples R China [2]Tsinghua Univ, Sch Med, Beijing, Peoples R China [3]Kunming Med Univ, Affiliated Hosp 1, Dept Plast Surg, 295 Xichang Rd, Kunming 650032, Yunnan, Peoples R China
出处:
ISSN:

关键词: Animal model Fat grafting Fat survival rate Microvessel density Meta-analysis Platelet-Rich fibrin

摘要:
Background Autologous fat grafting has been widely used in plastic and reconstructive surgery, but one of the main reasons for limiting its application is the high resorption rate. Platelet-rich fibrin (PRF) is a new generation of platelet concentrate that has recently been used to improve the survival rate of fat grafts. The purpose of this study was to evaluate the effect of PRF on fat grafting. Methods Animal studies in four databases (PubMed, Cochrane library, Ovid, and Wan fang database) were searched up to July 2019. A meta-analysis was performed to compare PRF + fat grafting and fat grafting alone or platelet-rich plasma (PRP) + fat grafting in animal models. Result Six studies with 83 animals (123 fat graftings) were included in our meta-analysis. The fat survival rate (mean difference (MD) 0.14, P < 0.00001) and the microvessel density (MVD) (standardized mean difference 4.20, P = 0.02) of the PRF + fat group were significantly higher than that of the fat alone group. There was no significant difference between the PRF + fat group and PRP + fat group in the fat survival rate (MD 0.05, P = 0.06). Conclusion This study found that PRF combined with fat grafting may have an effect on improving the survival rate and MVD of fat grafts. However, when comparing the effects of PRF and PRP on the fat survival rate, there is currently no clear evidence to prove the difference between them. More preclinical and clinical studies are necessary to further clarify the effect of PRF on fat grafting in humans. No Level Assigned This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors .

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 4 区 医学
小类 | 4 区 外科
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 外科
JCR分区:
出版当年[2020]版:
Q3 SURGERY
最新[2023]版:
Q2 SURGERY

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者机构: [1]Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing, Peoples R China
通讯作者:
通讯机构: [3]Kunming Med Univ, Affiliated Hosp 1, Dept Plast Surg, 295 Xichang Rd, Kunming 650032, Yunnan, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:53731 今日访问量:1 总访问量:1666 更新日期:2024-11-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 昆明医科大学第一附属医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西昌路295号(650032)